» Articles » PMID: 33061634

Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Oct 16
PMID 33061634
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aimed to investigate the associations between the preoperative prognostic nutritional index (PNI), systemic immune-inflammation index (SII) and overall survival (OS) and cancer-specific survival (CSS) in high-risk non-muscle-invasive bladder cancer (NMIBC) patients who received intravesical instillation of Bacillus Calmette-Guerin (BCG) after transurethral resection of bladder tumour (TURBT).

Patients And Methods: We retrospectively collected data from 387 high-risk NMIBC patients between January 2004 and December 2014. PNI was calculated as total lymphocyte count (10/L)×5+albumin concentration (g/L). SII was calculated as neutrophil count (10/L)×platelet count (10/L)/lymphocyte count (10/L). The cutoff values of PNI and SII were determined through receiver operating characteristic (ROC) analysis. OS and CSS were estimated by Kaplan-Meier analysis. The Log rank test was used to compare differences between the groups. Univariate and multivariate Cox regression analyses were performed to assess the predictive values of PNI and SII for OS and CSS. Additionally, highest-risk NMIBC patients were also divided into low or high groups according to PNI and SII. The OS and CSS of highest-risk NMIBC patients were estimated using Kaplan-Meier analysis with the Log rank test.

Results: The patients were divided into two groups according to the cutoff values of PNI (<50.17 vs ≥50.17) and SII (<467.76 vs ≥467.76). Kaplan-Meier analysis revealed that low PNI and high SII were associated with poorer OS and CSS in high-risk NMIBC patients. Univariate and multivariate Cox regression analyses revealed that PNI and SII were independent predictive factors for OS and CSS. Kaplan-Meier analysis also revealed that low PNI and high SII were related to poorer OS and CSS in highest-risk NMIBC patients.

Conclusion: These results suggest that preoperative PNI and SII, based on standard laboratory measurements, may be useful noninvasive, inexpensive and simple tools for predicting the long-term survival of high-risk NMIBC patients who received intravesical instillation of BCG after TURBT.

Citing Articles

Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis.

Sun J, Li Z, Zhu X Front Oncol. 2025; 14:1486389.

PMID: 39917365 PMC: 11798790. DOI: 10.3389/fonc.2024.1486389.


Prognostic significance of systemic immune inflammation index in patients with urothelial carcinoma: a systematic review and meta-analysis.

Zheng L, Wang Z, Li Y, Ge S, Zeng Z, Gan L Front Oncol. 2025; 14:1469444.

PMID: 39763606 PMC: 11700819. DOI: 10.3389/fonc.2024.1469444.


Geriatric nutritional risk index and controller nutritional status score before metastatic first-line chemotherapy predict survival in patients over 70 years of age with metastatic bladder cancer.

Balcik O, Demir B, Ilhan Y, Akagunduz B Front Med (Lausanne). 2024; 11:1376607.

PMID: 38803342 PMC: 11129015. DOI: 10.3389/fmed.2024.1376607.


Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters.

He Y, Pan C, Zhang Y, Lv M, Yang B BMC Urol. 2024; 24(1):67.

PMID: 38528549 PMC: 10964628. DOI: 10.1186/s12894-024-01437-4.


Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma.

Zheng J, Peng L, Zhang S, Liao H, Hao J, Wu S Front Immunol. 2023; 14:1275033.

PMID: 38053997 PMC: 10694229. DOI: 10.3389/fimmu.2023.1275033.


References
1.
Muller I, Munder M, Kropf P, Hansch G . Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?. Trends Immunol. 2009; 30(11):522-30. DOI: 10.1016/j.it.2009.07.007. View

2.
Noh G, Han J, Cho M, Hur H, Min B, Lee K . Impact of the prognostic nutritional index on the recovery and long-term oncologic outcome of patients with colorectal cancer. J Cancer Res Clin Oncol. 2017; 143(7):1235-1242. DOI: 10.1007/s00432-017-2366-x. View

3.
Thiel T, Ryk C, Renstrom-Koskela L, Steineck G, Schumacher M, Wiklund N . Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer. World J Urol. 2018; 37(1):155-163. PMC: 6510863. DOI: 10.1007/s00345-018-2375-7. View

4.
Prabawa I, Bhargah A, Liwang F, Tandio D, Tandio A, Wiradewi Lestari A . Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer. Asian Pac J Cancer Prev. 2019; 20(3):863-868. PMC: 6825764. DOI: 10.31557/APJCP.2019.20.3.863. View

5.
Tomita M, Ayabe T, Maeda R, Nakamura K . Comparison of Inflammation-Based Prognostic Scores in Patients undergoing Curative Resection for Non-small Cell Lung Cancer. World J Oncol. 2018; 9(3):85-90. PMC: 6031234. DOI: 10.14740/wjon1097w. View